Pancreatic Cancer Research

ResearcherPurdue University West LafayetteNo recent work listed

Jie Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2540-7494; OpenAlex author ID A5100742387. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
9
Papers, trials and grants by year

2016: 1 paper · 2017: 2 papers

Papers 3

  1. Verteporfin suppresses cell survival, angiogenesis and vasculogenic mimicry of pancreatic ductal adenocarcinoma via disrupting the YAP-TEAD complex. Last author DOI 10.1111/cas.13138↗
  2. Hypoxia induces oncogene yes-associated protein 1 nuclear translocation to promote pancreatic ductal adenocarcinoma invasion via epithelial-mesenchymal transit… Last author DOI 10.1177/1010428317691684↗
  3. Plk1 inhibition enhances the efficacy of gemcitabine in human pancreatic cancer. Co-author DOI 10.1080/15384101.2016.1148838↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Honglong Wei · 2 shared papers, 2017 · strength 0.15
  2. Xueying Sun · 2 shared papers, 2017 · strength 0.15
  3. Tao Li · 1 shared paper, 2017 · strength 0.07
  4. Jingtao Zhong · 1 shared paper, 2017 · strength 0.07
  5. Patrick G. Schweickert · 1 shared paper, 2016 · strength 0.06
  6. Yi Yang · 1 shared paper, 2016 · strength 0.06
  7. Nihal Ahmad · 1 shared paper, 2016 · strength 0.06
  8. Xiaoqi Liu · 1 shared paper, 2016 · strength 0.06
  9. Stephen F Konieczny · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.